Guest guest Posted December 21, 2010 Report Posted December 21, 2010 A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 21, 2010 Report Posted December 21, 2010 You forgot about cancer. I know athletes that used AAS and ended up getting cancer. Edwin Freeman, Jr. San Francisco, CA Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 The article only looked at cardiac effects of AAS. There is an alarming number of suicides, amongst AAS users. The bodies are there if you just look for them. Ralph Giarnella MD Southington Ct. USA ________________________________ From: " efreem3407@... " <efreem3407@...> Supertraining Sent: Wed, December 22, 2010 12:43:37 AM Subject: Re: Anabolic steroids- where are the bodies. You forgot about cancer. I know athletes that used AAS and ended up getting cancer. Edwin Freeman, Jr. San Francisco, CA Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 A common refrain amongst apologists against anabolic steroids is: The bodies are in the cemetary only the death certificate does not state they died from steriods. Kenny Croxdale Rio Rancho, NM Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 Ralph, What data do you have to back that statement up on suicides? Evidently, you have yet to find the bodies. So, either they aren't there or you don't know where to look. Which is it? Kenny Croxdale Rio Rancho, NM Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 You apparently missed the point of the article. There are numerous case studies of young weight lifters and body builders who abused AAS and died and subsequently underwent autopsy. These are individuals who had no other risk factors for heart disease. When a person dies of heart disease because of a bad diet the death certificate does not state that they died because they had a poor diet. It just states they died of a heart attack. Death certificates do not state that an individual died because of obesity nor does it state that they died as the result of smoking. Death certificates list the conditions caused by these conditions such as heart diseasea, diabetes, emphysema or copd. As a matter of fact in my state (Connecticut) only recently has there been a box to check off is smoking might have been a contributing cause of this persons death. There is no box to check for alcohol abuse, obesity or eating at Mcs. a There is plenty of science available in the literature concerning the dangers of AAS, however the AAS apologists conveninetly ignore the science. Ralph Giarnella MD Southington Ct. USA ________________________________ From: " KennyCrox@... " <KennyCrox@...> Supertraining Sent: Wed, December 22, 2010 7:00:59 AM Subject: Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists against anabolic steroids is: The bodies are in the cemetary only the death certificate does not state they died from steriods. Kenny Croxdale Rio Rancho, NM Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 The same article cited several studies with the data concerning suicides. Take the time and go to your local hospital library and you will find the original article. You can read it for yourself. As I stated in my original post the article lists 99 published studies on the subject of cardiac effects of AAS. ********************* a recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstract 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; ****************** Ralph Giarnella MD Southington Ct. USA ________________________________ From: " KennyCrox@... " <KennyCrox@...> Supertraining ; ragiarn@... Sent: Wed, December 22, 2010 7:09:31 AM Subject: Re: Anabolic steroids- where are the bodies. Ralph, What data do you have to back that statement up on suicides? Evidently, you have yet to find the bodies. So, either they aren't there or you don't know where to look. Which is it? Kenny Croxdale Rio Rancho, NM Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 I always chuckle when I read these posts about AAS usage and that the bodies are there if you look for them. I am certainly not an apologist for the usage of steroids, but I'm not a basher either.  If my competitive clientele use them at the risk of failing a drug test that is their business. I only ask that they disclose this to me so I can adjust the training. However, I do counsel them that I offer other options to raise testosterone without the negative effects.  When, in my opinion, you look at the big picture though, certain drugs introduced to the body on a regular short or long-term basis (including prescription drugs) run the risk of a variety of side effects.  Are some of those bodies... broken down, have chronic conditions and have passed due to steroid usage? Absolutely! But, what about " street drugs " or the abuse of pain medications?  How will one ever be able to actually make a definitive statement?  On a closing and much more positive note...I wish all of you a very Happy Holiday Season. I don't post much, but I read frequently. I appreciate all of your posts!  Best, Mark Cotton New Jersey, USA From: KennyCrox@... <KennyCrox@...> Subject: Re: Anabolic steroids- where are the bodies. Supertraining , ragiarn@... Date: Wednesday, December 22, 2010, 7:09 AM  Ralph, What data do you have to back that statement up on suicides? Evidently, you have yet to find the bodies. So, either they aren't there or you don't know where to look. Which is it? Kenny Croxdale Rio Rancho, NM Re: Anabolic steroids- where are the bodies. The article only looked at cardiac effects of AAS. There is an alarming number of suicides, amongst AAS users. The bodies are there if you just look for them. Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 One of my graduate students is gathering longevity data on athletes who threw the discus, shot, and hammer between 1960 and 1985. We are attempting to catalog the status of the top 25 athletes in each event for those years. Any information or advice would be appreciated. Tom Fahey Dept of Kinesiology California State University, Chico Chico, CA 95929-0330 Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 Ralph, You apparently can come up with defenitive data. Drug abuse of any medication cause health issues or leads you down the road to a quick demise. Drinking too my water will kill you, hyponatramia. There is plenty of data form medical experts and the federal government that counter your statements. Here a quick look at some of it. http://www.youtube.com/watch?v=z0LEj8IPHGU & feature=related I will be more than happy to provide with a plethra of data that refutes what you've presented. With that said, I am a proponent of just tell the truth and let the chips fall... Kenny Croxdale Rio Rancho, NM Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 Tom, I was thinking about you when preparing my post on anabolic steroids. I believe that you made a comment in a post within the last two years concerning early deaths amongst athletes you knew and who were taking steroids. Perhaps you can comment on this topic. Ralph Giarnella MD Southington Ct. USA ________________________________ From: Tom Fahey <discusdoc@...> Supertraining Cc: tp_soccer3@... Sent: Wed, December 22, 2010 9:35:33 AM Subject: Re: Anabolic steroids- where are the bodies. One of my graduate students is gathering longevity data on athletes who threw the discus, shot, and hammer between 1960 and 1985. We are attempting to catalog the status of the top 25 athletes in each event for those years. Any information or advice would be appreciated. Tom Fahey Dept of Kinesiology California State University, Chico Chico, CA 95929-0330 Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 The variety of side effects of AAS on women though, now there's a bad idea all around... few prescription drugs for a legal purpose make a woman into a man (at least take her to the point of just having things well, nipped on in an operation! or cause sufficient changes to make the gender indistinct?) I've always said that if a woman has to join the male race to succeed, she's in the wrong sport. Ok one more thing I've said - just because men feel it's necessary to take steroids does not mean we ladies need follow them down this particular path... No offense, but my personal opinion is that it takes a better man to not use the drugs and succeed. To thine own self be true. the Phantom aka Schaefer, lifetime drug free powerlifter Denver, Colorado, USA Re: Anabolic steroids- where are the bodies. The article only looked at cardiac effects of AAS. There is an alarming number of suicides, amongst AAS users. The bodies are there if you just look for them. Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 Kenny, I would appreciate it if you could provide me with scientific data in peer reviewed journals showing that anabolic steroids used in supraphysioligic doses are safe. I have yet to see an single scientifi article or study that valididates the use of suprphysiologic does of AAS. I had seen the you tube you cited (not a very scientific or credible venue) and the info is not very convincing and is anecdotal at best. I gave you studies in which the bodies of real body builders and weight lifters were studied in detail by scientists. You asked the question in a previous post " where are the bodies " . I gave you the bodies. Do you have evidence that refutes the autopsies or denies the validity of the autopsies who those young men who died because they were convinced that what they were doing was safe. I think it is important to underline the fact that this discussion concerns supraphysiologic doses of anabolic steroids and not therapeutic use of hormones. The topic of therapeutic use requires another discussion. Ralph Giarnella MD Southington Ct. USA. ________________________________ From: " KennyCrox@... " <KennyCrox@...> Supertraining Sent: Wed, December 22, 2010 12:03:42 PM Subject: Re: Anabolic steroids- where are the bodies. Ralph, You apparently can come up with defenitive data. Drug abuse of any medication cause health issues or leads you down the road to a quick demise. Drinking too my water will kill you, hyponatramia. There is plenty of data form medical experts and the federal government that counter your statements. Here a quick look at some of it. http://www.youtube.com/watch?v=z0LEj8IPHGU & feature=related I will be more than happy to provide with a plethra of data that refutes what you've presented. With that said, I am a proponent of just tell the truth and let the chips fall... Kenny Croxdale Rio Rancho, NM Re: Anabolic steroids- where are the bodies. A common refrain amongst apologists for anabolic steroids is : Where are the bodies? The bodies are in the cemetary ony the death certificated does not state they died from steroids. The most likely cause of death heart disease. It might be cardiac arrhythmia or acute MI. There is an excellent article in the American Journal of Cardiology which reviews A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. It cites 99 articles covering this topic. If you are interested in this topic go to your local hospital Library and check out : Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - Because of copyright and space I cannot put the article here but I have taken the time to excerpt some of the information I thought might be pertinent along with the articles or journals cited. You are not likely to find these studies in your typical muscle magazine or website. Some of these studies date back to the mid 80s and 90s. The information is not new just conveniently ignored. *********************** Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - Copyright © 2010 The American College of Cardiology - AAS and abnormal plasma lipoproteins AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several studies suggest that AAS abuse in athletes increase low-density lipoprotein (LDL) levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , [43] , [44] By some estimates, these lipoprotein abnormalities increase the risk for coronary artery disease by three- to sixfold. [14] , [45] 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S.: Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. 19-23.1988; Abstrac 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. 970- 972.1996; Abstract 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J Cardiol 17. 281-288.1987; Abstract 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36. 1132-1140.1996; Abstract 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders during and after self- administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sport Med 38. 253-259.2004; 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 36. 483-488.2006; Abstract 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; Abstract 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameteres in body builders. Int J Sports Med 10. 62-66.1989; Abstract 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract AAS, acute MI, and sudden death Alarming data have linked AAS with fatal events, although these are mostly case-control studies and case reports of acute coronary syndromes, MIs, and ventricular arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. 48-53.2007; Abstract 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a connection?. Med Hypotheses 35. 27-31.1991; Abstract 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. 411-412.1996; Citation 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. 507- 508.1992; Citation 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sport Exer 26. 408-413.1994; 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 50. 222- 223.1996; Abstract a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested primary cardiac pathology in 1/3, [23] 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, with others being attributed to suicide, hepatic coma, and malignancy. 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21. 225-227.2000; Abstrac 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former athletes. Sports Med 2002. 83-84.2002; 2 Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and experienced sudden cardiac arrest. Postmortem examination revealed ventricular hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was attributed to arrhythmic sudden death secondary to AAS abuse. 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111. 261-264.1998; Abstrac McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted to AAS abuse but lacked cardiac risk factors. The patient presented with markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family history of premature atherosclerosis or cardiac events. Within a month of discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 mg/dl. 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol62.164.1988; Citation 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete who abused nandrolone and presented with an acute MI without traditional cardiac risk factors. Acute angiography revealed extensive left anterior descending coronary artery thrombosis, which was managed by thrombolysis. Angiography in the subacute phase confirmed very mild luminal irregularity at the site of previous thrombosis. 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62. 174-176.1993; Citation The most commonly observed arrhythmias, typically occurring during physical exertion, include atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and supraventricular and ventricular ectopic beats. [95] 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; Abstract Dickerman et al [96] reported a 20-year-old male bodybuilder who self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy indicated LVH with a cardiac mass >2 times the upper limit of normal. 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. 172-173.1995; Abstract ****************** Ralph Giarnella MD Southington Ct. USA Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 I agree with your observations. However the therapeutic use of hormones as a safe preventive is not totally clear because there are no large long term studies done. It must be recalled here that for many yearsHRT for women was not only considered safe but it was purported to decrease the incidence of heart disease. I remember attending hospital lectures given by a world renowned professor of Gynecology touting the cardiac benefits of HRT. He pointed out that 50% of women died as a result of heart disease and stroke and HRT could decrease this. He noted that there was no significant increase in cancer of the breast associated with it suse. It was only after a large study looking at 10s of thousands of women for a decade did it become clear that HRT not only increased the risk for cancer in women who had taken it for a prolonged period but that instead of protecting them from heart disease it actually increased their risk of cardiovascular disease. This was while using therapeutic doses of the hormone. Women felt significantly better on these hormones, were more energetic and vibrant and even appeared to be younger. However when compared to a group of women matched for age and not taking HRT over the same time period more of the women on HRT were dying of cancers and heart disease. Nowadays HRT for women is used for a short period of time (3-5) years to help some women overcome the perimenopausal symptoms which can be very dibilitating for many. It should be noted that it was the long term use that increased the risk and not the short term risk. Many a medicine has been shown to safe in limited controlled studies (several thousand patients) for short period of time (1-2 years) only to be found to unsafe when it was used by millions. Sometimes it takes a large pool of individuals to find statistically significant data to show the dangers. Perfect examples are the widely publicized Vioxx as well as Avandia cases. Both were shown to be safe in initial small studies. It was not until they were prescribed to millions that a statisticaly significant increase in deaths became more evident. I am not aware of any large (1000s of subjects) double blind controlled (neither the subject nor the investigator knows who is getting the real pill or the placebo) long term (5+ years) studies on the safetyo male HRT. Until such a study is done physicians will be reluctant to hand out prescriptions for HRT to individuals with levels within acceptable normal ranges. All it takes are a few wrongful death lawsuits. Ralph Giarnella MD Southington Ct. USA ________________________________ From: Casler <bioforce.inc@...> Supertraining Sent: Wed, December 22, 2010 11:07:57 AM Subject: Anabolic steroids- where are the bodies. Ralph Giarnella MD wrote: You apparently missed the point of the article. There are numerous case studies of young weight lifters and body builders who abused AAS and died and subsequently underwent autopsy. These are individuals who had no other risk factors for heart disease. When a person dies of heart disease because of a bad diet the death certificate does not state that they died because they had a poor diet. It just states they died of a heart attack. Death certificates do not state that an individual died because of obesity nor does it state that they died as the result of smoking. Death certificates list the conditions caused by these conditions such as heart diseasea, diabetes, emphysema or copd. As a matter of fact in my state (Connecticut) only recently has there been a box to check off is smoking might have been a contributing cause of this persons death. There is no box to check for alcohol abuse, obesity or eating at Mcs. a There is plenty of science available in the literature concerning the dangers of AAS, however the AAS apologists conveninetly ignore the science. Casler writes: I think it is extremely important to take an informed viewpoint that looks at all the implications. Anabolic Steroids and other endocrine drugs can be abused or they can be used. This means don't be an apologist nor an alarmist regarding the subject. We also need to disassociate their medical use with the abuse and cheating usage in sports. While you can draw associations with cases that may have been caused by abuse, we should not let that hamper the proper medical use of such medications to improve health and the quality of life. There is MUCH evidence that the proper medical use will NOT cause heart and coronary disease, but it will reduce or prevent it. The hysteria that surrounds hormonal abuse is likely warranted, but it need be tempered and disconnected from their positive medical implementation. Insulin is another hormone more commonly used in a medical sense and is arguably more anabolic than testosterone. It is also even more dangerous if abused or used improperly, so I think we need adapt the same viewpoint to all exogenous hormonal use. Broad brush hand waving creates a strange phenomenon whereby the " good " that can be done thwarts the amount of research that needs to be carried out to be truly helpful. HRT (hormone replacement therapy) is beginning to gain an interest and it would seem that if the " balancing act " of using the medications properly is more sophisticated that it will in fact REDUCE cancers, heart disease, sarco and osteopenia, diabetes, metabolic syndrome, and many other ailments that manifest (especially) males as they suffer a reduction in testosterone production. Enlarged hearts and other heart conditions assigned to steroid abuse may certainly be true, but years before steroid abuse was around these same conditions fell many former athletes. I'm just suggesting not to throw the baby out with the bath water. I think in the future, if we can get beyond this publicity generated hysteria, so that endocrine science will advance and health and the quality of life will be enhanced and improved with greater understanding and implementation. Just like we now know more about nutrition, and how manipulating our intakes can be positive, we will likely see that we can also learn how to control hormonal/endocrine levels to a better and healthier result. Regards, Casler TRI-VECTOR 3-D Training Systems Century City, CA -II-----II- Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 Casey, I stated that the Real Sports report with Armen Keteyian (currently with CBS News) was " a quick look at it " ...that meanint it provided some information on the subject. I have some additional in depth documentation on the matter. As I previously stated, abuse of AAS or for that matter any other medication will eventually cause problems. Please re-read my post. Kenny Croxdale, CSCS Rio Rancho, NM Re: Anabolic steroids- where are the bodies. Kenny, I don't think that an HBO story of steroid use covering what a few people call the lack of evidence supporting the dangers of using or abusing steroids a viable counter to the sample of evidence Dr. Ralph is providing, which is the tip of the iceberg when it comes to research regarding the use and abuse of AAS. ===================== Quote
Guest guest Posted December 23, 2010 Report Posted December 23, 2010 Sigh. Without a baseline testosterone on most guys, we've no idea where their levels were at their peak of health/youth. Obviously the same applies to women... I know of one good PL gal who had LOW testosterone - probably in the thinking espoused below, received HRT for her low test? However it did not affect her lifting, and she was top ranked... How do we know about her test level? She had to at one point take a blood test to prove that her levels were not only normal, but actually low...because of a failed " lie detector " test lol. Got so nervous (the woman does NOT even drink soda or well, coffee!) that she failed it. Another side issue with those tests where the nervous innocent get bailed in with the guilty but that's another topic.. So if a lady in her prime and best lifting days actually comes up clinically low in testosterone, perhaps some men are also " clinically low " and yet quite functional and arguably better than " just functional " ? How much of the testosterone/supplementation is mental/emotional - where is the study PROVING the efficacy of the usage too? Perhaps a nice double blind with the placebo effect...? Remember the " Star Trek " episode, " Mudd's Women " ? Youthful appearance and behavior may be as close as getting a good night's sleep and taking a day off from the " foxhole economy " right now...the " get your butt in your chair and keep your head down " stress is aging everyone IMHO! More chalk, less chair! Lastly - the argument about " where are the bodies " is the same bs you get from cigarette smokers - " it's not on the death certificate " . Never mind that well, a lot of cigarette smokers appear to be plenty dead from usage. Sure, some thrive on cigs...and likely some thrive on AAS and other less than desired practices? Putting drinking coffee in this list of items is a red herring. Sorry, but it's really not the worst practice and might arguably save lives at times lol. Perhaps such dangers are the lack of coffee, rather than inclusion . Thanks for the original posting, Dr. Ralph - and a Merry (non-AAS/nonWADA violating) Christmas to everyone here The Phantom aka Schaefer, CMT/RMT, competing powerlifter Denver, Colorado, USA Anabolic steroids- where are the bodies. The Phantom wrote - There's also the point of ethics in sport. Cheating is what you're doing if you breach the rules - and people scream quite loudly when someone say, breaks a rule on the field, right? If anything, people need to be less comfy about AAS and other cheats and perhaps return their thinking to a more level way of viewing ALL cheating as cheating. Casler writes: Hi , I agree and haven't suggested supporting cheating in athletic competition in any way, nor have I suggested that the " abuse " of steroids is positive in any way. My point is to be careful in the message sent regarding all uses of exogenous hormones, so that they do not get a broad brush demonization. The facts of the matter are that one of the key elements to aging, and the diseases of aging is the reduced and changing hormonal production and profile. This is an area that needs some serious research, especially in this age of Baby Boomers increasing in numbers. We have a healthcare problem of incredible proportion and hormonal profiling appears to offer some serious benefits. You would be hard pressed to find any major disease that is not related to hormone deficiency, or profile. And this too needs to be approached seriously and not too enthusiastically as a " fountain of youth " without the proper research. I find it a great challenge to age with various nutritional and training strategies to maintain health and performance. I think in the future we will have a better grasp on various methods of maintaining a more youthful and healthy endocrine profile. The results will hopefully be a reduction in age related diseases. It is important that the general public is not led into an association of any employment of these means as cheating or dangerous when undertaken in a valid medical usage. My point is to make sure and define USE versus ABUSE. As well, there is also some discussion linking Steroid " abuse " /use to suicide. I find that a difficult case to make on its own. I think you could create a similar case to just being a teenager since they tend to commit suicide at an ALARMING rate. The real truth is likely somewhere in between. The answer is likely that the " emotional type " of person who feels the need to abuse drugs and or steroids is more likely to commit suicide. Most of them probably also drink coffee, and have other common practices, and environmental similarities but the correlation is not drawn. Rant over. . . . Regards, Casler TRI-VECTOR 3-D Training Systems Century City, CA -II-----II- Quote
Guest guest Posted December 23, 2010 Report Posted December 23, 2010 Hey Tom! L. Jay Silvester (former discus record holder and Olympic silver medalist) presented a paper at an NSCA conference about 15 years ago where he did just what you propose with discus throwers from his throwing days ('60's & '70's). He found no link between health problems and AA steroid use. I believe he was working at BYU at the time. Not sure of his present location. Best wishes! Dan Wathen, Youngstown (OH) State University, USA. > > One of my graduate students is gathering longevity data on athletes who threw the discus, shot, and hammer between 1960 and 1985. We are attempting to catalog the status of the top 25 athletes in each event for those years. Any information or advice would be appreciated. > > > Tom Fahey > Dept of Kinesiology > California State University, Chico > Chico, CA 95929-0330 > > > > > > Re: Anabolic steroids- where are the bodies. > > A common refrain amongst apologists for anabolic steroids is : Where are the > > bodies? The bodies are in the cemetary ony the death certificated does not > > state they died from steroids. The most likely cause of death heart disease. > > It might be cardiac arrhythmia or acute MI. > > There is an excellent article in the American Journal of Cardiology which > > reviews A total of 49 studies describing 1,467 athletes were reviewed to > > investigate the cardiovascular effects of the abuse of AAS. > > It cites 99 articles covering this topic. If you are interested in this topic > > go to your local hospital Library and check out : > > Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, > > Blood Pressure, Left Ventricular Dimensions, and > > Rhythm > > The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - > > Copyright © 2010 The American College of Cardiology - > > Because of copyright and space I cannot put the article here but I have taken > > the time to excerpt some of the information I thought might be pertinent along > > with the articles or journals cited. > > You are not likely to find these studies in your typical muscle magazine or > > website. Some of these studies date back to the mid 80s and 90s. The > > information is not new just conveniently ignored. > > *********************** > > Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, > > Blood Pressure, Left Ventricular Dimensions, and Rhythm > > The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) - > > Copyright © 2010 The American College of Cardiology - > > AAS and abnormal plasma lipoproteins > > AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several > > studies suggest that AAS abuse in athletes increase low-density lipoprotein > > (LDL) > > levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein > > (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] , > > [43] , [44] > > By some estimates, these lipoprotein abnormalities increase > > the risk for coronary artery disease by three- to sixfold. [14] , [45] > > 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer > > D.S.: Androgenic anabolic steroids and arterial structure and function in male > > bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract > > 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar > > > > A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins, > > blood > > pressure, and liver function in amateur bodybuilders. Int J Sports Med 9. > > 19-23.1988; Abstrac > > 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of > > serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42. > > 970- > > 972.1996; Abstract > > 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J > > Cardiol 17. 281-288.1987; Abstract > > 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M., > > Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained > > subjects. J Clin > > Pharmacol 36. 1132-1140.1996; Abstract > > 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., > > Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders > > during and after self- > > administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract > > 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid > > profile of body builders with and without self-administration of anabolic > > steroids. Eur J > > Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K > > 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.: > > Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). > > Br J Sport > > Med 38. 253-259.2004; > > 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies > > > > J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic > > steroids. Eur J > > Clin Invest 36. 483-488.2006; Abstract > > 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic > > steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004; > > Abstract > > 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini > > M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and > > echocardiographic parameteres in body builders. Int J Sports Med 10. > > 62-66.1989; Abstract > > 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels. > > A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract > > AAS, acute MI, and sudden death > > Alarming data have linked AAS with fatal events, although these are mostly > > case-control studies and case reports of acute coronary syndromes, MIs, and > > ventricular > > arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88] > > 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G., > > Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and > > > > toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121. > > 48-53.2007; Abstract > > 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac > > toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract > > 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a > > > > connection?. Med Hypotheses 35. 27-31.1991; Abstract > > 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a > > 21-year-old body builder with anabolica abuse. Br J Clin Pract 50. > > 411-412.1996; Citation > > 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic > > steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124. > > 507- > > 508.1992; Citation > > 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid > > user. Med Sci Sport Exer 26. 408-413.1994; > > 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with > > extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract > > 50. 222- > > 223.1996; Abstract > > a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested > > > > primary cardiac pathology in 1/3, [23] > > 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of > > anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract > > recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths, > > > > with others being attributed to suicide, hepatic coma, and malignancy. > > 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased > > premature mortality of competitive powerlifters suspected to have used anabolic > > agents. Int J Sports Med 21. 225-227.2000; Abstrac > > 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former > > athletes. Sports Med 2002. 83-84.2002; 2 > > Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and > > experienced sudden cardiac arrest. Postmortem examination revealed ventricular > > hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was > > attributed to arrhythmic sudden death secondary to AAS abuse. > > 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents) > > and sudden death†" a case report and review of the literature. Int J Legal Med > > 111. 261-264.1998; Abstrac > > McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted > > to AAS abuse but lacked cardiac risk factors. The patient presented with > > markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family > > > > history of premature atherosclerosis or cardiac events. Within a month of > > discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35 > > mg/dl. > > 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial > > infarction in a 22-year-old world class weight lifter using anabolic steroids. > > Am J Cardiol62.164.1988; Citation > > 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation > > Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete > > who abused nandrolone and presented with an acute MI without traditional cardiac > > > > risk factors. Acute angiography revealed extensive left anterior descending > > coronary artery thrombosis, which was managed by thrombolysis. Angiography in > > the subacute phase confirmed very mild luminal irregularity at the site of > > previous thrombosis. > > 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic > > steroids. Ulster Med J 62. 174-176.1993; Citation > > The most commonly observed arrhythmias, typically occurring during physical > > exertion, include atrial fibrillation, ventricular fibrillation, ventricular > > tachycardia, and supraventricular and ventricular ectopic beats. [95] > > 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and > > cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007; > > > > Abstract > > Dickerman et al [96] reported a 20-year-old male bodybuilder who > > self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy > > indicated LVH with a cardiac mass >2 times the upper limit of normal. > > 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death > > > > in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86. > > 172-173.1995; Abstract > > ****************** > > Ralph Giarnella MD > > Southington Ct. USA > > Quote
Guest guest Posted December 23, 2010 Report Posted December 23, 2010 The book, Death In the Locker Room (Bob Goldman 1984) has an introduction from B. Zeigler M.D. - the man that created the first AAS with Ciba Pharmaceutical in the mid 50's. In the introduction Zeigler essentially apologizes for bringing steroids to the US. He saw how quickly AAS use and abuse became - as he states it - an epidemic among athletes. The man who created the first American Steroid witnessed first hand the bodies begin to pile up. On a side not the bibliography of the book alone is nearly 45 pages. Casey Gallagher CSCS Snohomish, WA USA > > You apparently missed the point of the article. There are numerous case > studies of young weight lifters and body builders who abused AAS and died > and subsequently underwent autopsy. These are individuals who had no other > risk factors for heart disease. When a person dies of heart disease because > of a bad diet the death certificate does not state that they died because > they had a poor diet. It just states they died of a heart attack. Death > certificates do not state that an individual died because of obesity nor > does it state that they died as the result of smoking. Death certificates > list the conditions caused by these conditions such as heart diseasea, > diabetes, emphysema or copd. As a matter of fact in my state (Connecticut) > only recently has there been a box to check off is smoking might have been a > contributing cause of this persons death. There is no box to check for > alcohol abuse, obesity or eating at Mcs. a > > There is plenty of science available in the literature concerning the > dangers of AAS, however the AAS apologists conveninetly ignore the science. > > Casler writes: > > I think it is extremely important to take an informed viewpoint that looks > at all the implications. Anabolic Steroids and other endocrine drugs can be > abused or they can be used. This means don't be an apologist nor an > alarmist regarding the subject. > > We also need to disassociate their medical use with the abuse and cheating > usage in sports. > > While you can draw associations with cases that may have been caused by > abuse, we should not let that hamper the proper medical use of such > medications to improve health and the quality of life. There is MUCH > evidence that the proper medical use will NOT cause heart and coronary > disease, but it will reduce or prevent it. The hysteria that surrounds > hormonal abuse is likely warranted, but it need be tempered and disconnected > from their positive medical implementation. > > Insulin is another hormone more commonly used in a medical sense and is > arguably more anabolic than testosterone. It is also even more dangerous if > abused or used improperly, so I think we need adapt the same viewpoint to > all exogenous hormonal use. Broad brush hand waving creates a strange > phenomenon whereby the " good " that can be done thwarts the amount of > research that needs to be carried out to be truly helpful. > > HRT (hormone replacement therapy) is beginning to gain an interest and it > would seem that if the " balancing act " of using the medications properly is > more sophisticated that it will in fact REDUCE cancers, heart disease, sarco > and osteopenia, diabetes, metabolic syndrome, and many other ailments that > manifest (especially) males as they suffer a reduction in testosterone > production. > > Enlarged hearts and other heart conditions assigned to steroid abuse may > certainly be true, but years before steroid abuse was around these same > conditions fell many former athletes. > > I'm just suggesting not to throw the baby out with the bath water. I think > in the future, if we can get beyond this publicity generated hysteria, so > that endocrine science will advance and health and the quality of life will > be enhanced and improved with greater understanding and implementation. > Just like we now know more about nutrition, and how manipulating our intakes > can be positive, we will likely see that we can also learn how to control > hormonal/endocrine levels to a better and healthier result. > > Regards, > > Casler > TRI-VECTOR 3-D Training Systems > Century City, CA > -II-----II- > > > > > Quote
Guest guest Posted December 23, 2010 Report Posted December 23, 2010 Dr. Klostergaard is correct about the low dosage taken by throwers from that time. I published a paper on HDL levels in throwers and weight lifters during steroid cycles circa 1982 (One athlete had a cholesterol of 320 mg/dL and an HDL of 12). Their doses were only slightly higher than therapeutic doses, followed by 4-6 weeks abstinence. Also, few athletes used growth hormone. Still, steroid researchers warned of premature death, even in those days. We should have data on 750 throwers in a month or so. Tom Fahey Cal State U., Chico Re: Anabolic steroids- where are the bodies. All, Having experienced the AAS world directly as it existed in powerlifting, and tangentially as it was in the track and field throwing events, from the late 60’s up until the mid-80’s, I would like to ask this discussion to not overlook the point made by Dr. Giarnella: supra-physiological. In my experience, those who used AAS initially, likely a strong majority, generally kept to doses within or at least close to FDA guidelines, interspersed with phases of abstinence. Over time, I noticed this practice was gradually being displaced by reckless dose-escalation, stacking of agents, both oral and injectable, and a reluctance to “get cleanâ€, even for a brief period of time. So while the incidence of drug use during that period (1960-1985) was indeed likely very high as noted, it was not initially typified by the prevalent insanity that came later, circa late 70’s and onward: the latter being one of the major reason I elected to stop use personally, along with the unknowns regarding use over many years. Just my $0.02... Regards and Happy holidays! ====================== Quote
Guest guest Posted December 24, 2010 Report Posted December 24, 2010 Abuse of anything is a bad thing, by definition, and AAS are no exception. Still, I am taken aback at the seeming tacit acceptance of confounding bias in the studies cited here. Studying the results of abuse of AAS by body-builders and young weight lifters - really? I would be more interested in almost any other group of AAS abusers; many bodybuilders put their hearts under incredible stresses by cycling through dangerous levels of dehydration (among other things - many of which are also related to cardiac stress/risk). Young weightlifters have the least experience/guidance/restraint for abuses of any kind, often indulging to the highest levels. Tye W. Botting, PhD Springfield, VA, USA Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.